<?xml version="1.0" encoding="UTF-8"?>
<p id="Par42">As described earlier, innate and adaptive immune responses contribute to the pathogenesis of COVID-19. Some evidence exists to suggest that modulation of these processes in patients with kidney failure may have consequences for disease outcomes. Despite some early small, uncontrolled studies showing the opposite
 <sup>
  <xref ref-type="bibr" rid="CR183">183</xref>,
  <xref ref-type="bibr" rid="CR184">184</xref>
 </sup>, a report from Japan showed substantially higher mortality among patients on maintenance haemodialysis with COVID-19 than among non-dialysis patients, although this difference in mortality could be due to the older age of patients on haemodialysis
 <sup>
  <xref ref-type="bibr" rid="CR185">185</xref>
 </sup>. Two further studies from the UK and Italy also reported significantly higher mortality among patients on haemodialysis than among the non-dialysis population
 <sup>
  <xref ref-type="bibr" rid="CR162">162</xref>,
  <xref ref-type="bibr" rid="CR186">186</xref>
 </sup>. In the Italian study, ARDS was probably the cause of death among hospitalized patients on haemodialysis
 <sup>
  <xref ref-type="bibr" rid="CR162">162</xref>
 </sup>.
</p>
